ESCULON LLC
A novel small-bore chest tube device that prevents clogging and maintains post-surgical fluid drainage in cardiothoracic patients
- Sector
- Medtech
- Headquarters
- OMAHA, NE
- Founded
- 2016
- Latest Form D
- $970K, Jun 2017
- Total capital
- $1.9M
- Federal grants
- $930K
- 2 awards · 2016–2017
- Rank in peer group#429 of 477
- Private capital raised
- $970K
- 1 Form D · last Jun 2017
- 112 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 2 pending · first 2019
- Rank in peer group#155 of 477
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$970K
- Federal grantNSF · Phase II · SBIR Phase II: Novel Device for Maintaining Continuous Fluid Drainage in Small-Bore Chest Tubes after Cardiothoracic Surgery$750K
- Federal grantNSF · Phase I · SBIR Phase I: Novel Device for Maintaining Continuous Fluid Drainage in Small-Bore Chest Tubes after Cardiothoracic Surgery$180K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
18months
from ESCULON LLC’s first federal award to its first private round.
- First federal award · Jan 2016
- NSF · $180K
- First Form D · Jun 2017
- $970K · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#155 · top 32%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Evan LuxonResearcherDirectorLinked by 1 patent · $930K in grants as PI
- Alan CheslerDirectorNamed in SEC Form D filings
- Carter MeyerDirectorNamed in SEC Form D filings
- Danial BurnettDirectorNamed in SEC Form D filings
- Deepak GangaharDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 3- PendingDevices And Methods For Managing Chest DrainageUSPTOApplication 16297198
- GrantedDevices And Methods For Managing Chest DrainageUSPTOUS 10,265,442
- PendingDevices And Methods For Managing Chest DrainageUSPTOApplication PCTUS2017020791
Related companies, and why
- RAPID FORENSIC CELL TYPING, INC.Similar federal contract value in Medtech · null in contracts
- QUANTWORKS, INC.Similar federal contract value in Medtech · null in contracts
- Instapath Inc.Similar federal contract value in Medtech · null in contracts
- Birkeland Current LLCSimilar federal contract value in Medtech · null in contracts
- LAYERBIO INCSimilar federal contract value in Medtech · null in contracts
- Hura Imaging, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .